True. My point is that they were all intent for gross resection. They'll have removed much more tumour tissue than a typical biopsy that's for sure. The point is the prognosis of the selected set of patients for the trial should be significantly better than the 15-17mOS for the general population. Been discussed a thousand times but people still keep saying the same thing.
Market Data 
Markets 
AI
